Extremities market experiences slight gains due to expanded product portfoliosThe US Extremities Market experienced a slight gain in Q218 according to SmartTRAK Financial Dashboard, slightly lower than the rate anticipated in the US Extremities Market Overview. We anticipate the Extremities segment rebounding to achieve...
Among the many topics covered in the Q218 Extremities Market Recap are:
- Competition in Shoulders Heating Up
- Expanded Portfolios and Awareness Driving Continued Ankle Growth
- Extremities Fixation: Company Focus and New Product Intros Incite Growth
- Regulatory Highlights
The US Extremities Market experienced a slight dip in Q118, with sequential growth down from +8.4% to +6.9% that extended into all categories. While Q118 was relatively quiet, FDA clearances, new competitive products and new players in Shoulder, Ankles and Fixation should heat up the segment in 2018.
US Extremities Market experiences bump w/ new competition expected to fuel future growth
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 Extremities Market Recap and Financial Dashboard.
The US Extremities Market experienced an overall bump in Q417 growth that extended into all categories, with the exception of Ankle Replacement that took a slight dip in Q417, with sequential growth down from 18.1% to 16.1%. ...
Becker’s October 2017 Hospital Review webinar on “Current Trends for Success in Bundles and Strategies for Financial Changes: Orthopedics and Beyond” provides insights into the delicate balance healthcare institutions and surgeons are trying to maintain in this cost-conscious environment. Joseph Bosco, MD, and Richard Iorio, MD, of NYU Hospital for Joint Diseases shared their experience with everything from maximizing reimbursements and cost-effectively managing patient care while maintaining and improving clinical outcomes.
Dr. Bosco, holds the positions of Vice Chairman of Clinical Affairs, and Director of the Center for Quality and Patient Safety. Dr. Iorio serves as Chief of Adult Reconstruction and as the chair of the American Association of Hip and Knee Surgeons Committee on Advocacy and Healthcare Policy. Both Bosco and Iorio are principals with Labrador Healthcare Consulting, a value-based reimbursement strategies advisory firm. Below are highlights from the webinar:
New products and market segment penetration somewhat offsets slowing growth due to challenges faced by large industry players
By Lisa Mahan, VP, Content Development, Ortho and
Natasha Weeks, Editor/Sr. Analyst–Trauma
Large market players faced challenges that slightly dampened Q317 growth in the US Extremities market, with sequential growth down. Above market growth from smaller companies launching new products and increasing market penetration somewhat offset the negative effects of Zimmer Biomet ’s supply issues on the largest market segment – Shoulder Replacement.